Milatuzumab: a promising new agent for the treatment of lymphoid malignancies

Author: Mark Tomer   Martin Peter   Leonard John P   Niesvizky Ruben  

Publisher: Informa Healthcare

ISSN: 1354-3784

Source: Expert Opinion on Investigational Drugs, Vol.18, Iss.1, 2009-01, pp. : 99-104

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract